Advisory & Assessments

Some businessmen just have a knack for success: they know how to create it, grow it, manage it and even snatch it back from the brink of failure.

Bob ScullyPBS Interviewer

We bring an in the trenches perspective to provide a complete review from independent, senior operators. We have assisted hundreds of companies in reviewing their operations by providing objective insight and go forward options.

We have refined our diagnostic/assessment process over the years to provide an objective and comprehensive view into our clients’ strengths and weaknesses as well as provide go-forward options. The identification and analysis of the merits of each go-forward option is a key differentiator for us from consultants who may purport to provide operational assessment-like services. This analysis allows stakeholders to meet their fiduciary responsibility and to make well-informed decisions about the Company’s future strategic direction.

We also apply our deep domain and process expertise to provide unparalleled insight, support and advisory in various situations. We have advised numerous companies as well as some of the largest PE and VC firms including advising lead investor on 2 of the largest ever Biotech series A financings and the largest PE financing of an Agtech company.

Kirchner Group’s deep domain and process expertise enables us to provide unparalleled insight, support and service during every advisory engagement. In contrast to traditional consultants who simply produce reports, we not only perform comprehensive analysis and provide strategic recommendations, but also have the ability to roll up our sleeves and assist in execution.

Our professionals have extensive backgrounds running private and public companies and bring deep domain expertise to the table. We are experts at differentiating between perception and reality. Typically, the main decision facing investors and BOD members in complex situations is not only (a) what to do next, but also (b) how to do it. The Kirchner Group plays a key role in illuminating these options and can step in to help execute them if appropriate. Also unlike the approach typically taken by consultants, we don’t issue a report just based on what management told us — we apply our own operational experience and in-the-trenches perspective to separate the “wheat from the chaff”.

Our team consists of senior professionals who have been in your position before and understand how to dig deep, navigate all the angles and provide actual tangible value. Our advisory services and execution assistance is utilized in some cases as part of the preparatory work for a liquidity event.

We provide a variety of advisory services to individual companies as well as portfolios including:

  • independent third party assessment
  • company/technology positioning
  • transaction due diligence
  • company formation and structure
  • market entry and positioning
  • key partnerships and licensing agreements
  • global commercialization strategies

We also provide numerous other tailored advisory services. Each engagement is customized to the needs of the specific situation; thus, only services that are needed are provided.


Advisory Tombstones

Exosect Limited
Licensing Agreement With
Monsanto Company
Kirchner Group acted as an advisor to Exosect Limited
Alaska Permanent Fund 3
Alaska Permanent Fund
Advisor on due diligence in the Indigo Agriculture transaction.
Kirchner Group provided Advisory services.
Alaska Permanent Fund
Alaska Permanent Fund
Advisor on due diligence in the Denali Therapeutics Inc. transaction.
Kirchner Group provided Advisory services.
View All Kirchner Group Tombstones


Advisory Case Studies

Medical Device Company


  • Major capital purchase and thus, long sales cycle
  • Interest in exploring vertical market with little prior experience


  • Secured slot for a presentation at a national conference
  • Introduced to key potential strategic alliances in vertical market
  • Set up evaluation by two key opinion leaders
  • Recommended exploring lease and purchase conversion options to lower cost-of-entry barrier and shorten sales cycle


  • In use in major hospital/clinics
  • Target for possible acquisition by a large strategic acquirer
View All Kirchner Group Case Studies